Claudia María Rejano-Gordillo

Dr. Claudia María Rejano-Gordillo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Nature
Verified
Journal Article
Closed access
PDF file
LSLiliana M. Sanmarco
Liliana M. Sanmarco
JRJoseph M. Rone
Joseph M. Rone
Carolina Manganeli PolonioCarolina Manganeli Polonio
Carolina Manganeli Polonio
GLGonzalo Fernandez Lahore
Gonzalo Fernandez Lahore
FGFederico Giovannoni
Federico Giovannoni
FQFrancisco J. Quintana
Francisco J. Quintana

20 October 2022 in Nature
Verified
Journal Article
Closed access
PDF file
LSLiliana M. Sanmarco
Liliana M. Sanmarco
CCChun-Cheih Chao
Chun-Cheih Chao
YWYu-Chao Wang
Yu-Chao Wang
JKJessica E. Kenison
Jessica E. Kenison
ZLZhaorong Li
Zhaorong Li
FQFrancisco J. Quintana
Francisco J. Quintana

Verified
Journal Article
Open access
PDF file
CRClaudia María Rejano-Gordillo
Claudia María Rejano-Gordillo
BMBeatriz Marín-Díaz
Beatriz Marín-Díaz
AOAna Ordiales-Talavero
Ana Ordiales-Talavero
JMJaime M. Merino
Jaime M. Merino
FRFrancisco Javier González Rico
Francisco Javier González Rico
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
The aryl hydrocarbon receptor (AHR) is a markedly established regulator of a plethora of cellular and molecular processes. Its initial role in the detoxification of xenobiotic compounds has been partially overshadowed by its involvement in homeostatic and organ physiology processes. In fact, the discovery of its ability to bind specific target regulatory sequences has allowed for the understanding of how AHR modulates such processes. Thereby, AHR presents functions in transcriptional regulation, chromatin architecture modifications and participation in different key signaling pathways. Interestingly, such fields of influence end up affecting organ and tissue homeostasis, including regenerative response both to endogenous and exogenous stimuli. Therefore, from classical spheres such as canonical transcriptional regulation in embryonic development, cell migration, differentiation or tumor progression to modern approaches in epigenetics, senescence, immune system or microbiome, this review covers all aspects derived from the balance between regulation/deregulation of AHR and its physio-pathological consequences.

13 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ANAna Nacarino-Palma
Ana Nacarino-Palma
CRClaudia María Rejano-Gordillo
Claudia María Rejano-Gordillo
FRFrancisco Javier González Rico
Francisco Javier González Rico
AOAna Ordiales-Talavero
Ana Ordiales-Talavero
ÁRÁngel Carlos Román
Ángel Carlos Román
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
Non-small cell lung adenocarcinoma (NSCLC) bearing K-RasG12D mutations is one of the most prevalent types of lung cancer worldwide. Aryl hydrocarbon receptor (AHR) expression varies in human lung tumors and has been associated with either increased or reduced lung metastasis. In the mouse, Ahr also adjusts lung regeneration upon injury by limiting the expansion of resident stem cells. Here, we show that the loss of Ahr enhances K-RasG12D-driven NSCLC in mice through the amplification of stem cell subpopulations. Consistent with this, we show that K-RasG12D;Ahr−/− lungs contain larger numbers of cells expressing markers for both progenitor Clara (SCGB1A1 and CC10) and alveolar type-II (SFTPC) cells when compared to K-RasG12D;Ahr+/+-driven tumors. They also have elevated numbers of cells positive for pluripotent stem cells markers such as SOX2, ALDH1, EPCAM, LGR5 and PORCN. Typical pluripotency genes Nanog, Sox2 and c-Myc were also upregulated in K-RasG12D;Ahr−/− lung tumors as found by RNAseq analysis. In line with this, purified K-RasG12D/+;Ahr−/− lung cells generate larger numbers of organoids in culture that can subsequently differentiate into bronchioalveolar structures enriched in both pluripotency and stemness genes. Collectively, these data indicate that Ahr antagonizes K-RasG12D-driven NSCLC by restricting the number of cancer-initiating stem cells. They also suggest that Ahr expression might represent a good prognostic marker to determine the progression of K-RasG12D-positive NSCLC patients.

7 May 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
LMLaura Mosca
Laura Mosca
CPCristina Pagano
Cristina Pagano
MTMaria Giovanna Tafuri
Maria Giovanna Tafuri
GMGirolamo Di Maio
Girolamo Di Maio
CRClaudia María Rejano-Gordillo
Claudia María Rejano-Gordillo
Pasquale PerronePasquale Perrone
Pasquale Perrone
Background/Objectives: Chronic low-grade inflammation, underpinned by persistent activation of the NLRP3 inflammasome, is a central pathological mechanism in non-communicable diseases including cardiovascular disease, type 2 diabetes, inflammatory bowel disease, and neurodegeneration. Dietary polyphenols have been consistently associated with reduced inflammatory burden; however, the mechanisms underlying these effects remain incompletely understood. This review aims to characterize the gut microbiota–polyphenol–NLRP3 inflammasome axis as a central regulatory network through which diet modulates innate immune signaling and chronic inflammatory tone. Methods: A comprehensive narrative review of the available literature was conducted, integrating evidence from mechanistic studies in cell culture and animal models, microbiome research, metabolomics, and human epidemiological and interventional data. Results: The gut microbiota emerges as a critical biochemical intermediary that transforms dietary polyphenols into bioactive metabolites, including urolithins, phenyl-γ-valerolactones, protocatechuic acid, and short-chain fatty acids, with enhanced bioavailability and potent inflammasome-modulating properties. These compounds suppress NLRP3 activation through multiple converging mechanisms, including inhibition of NF-κB-dependent priming, mitochondrial quality control via mitophagy, Nrf2-mediated antioxidant responses, and HDAC inhibition. Evidence across cardiovascular, metabolic, neurological, and respiratory disease models supports the translational relevance of this axis. Conclusions: The microbiota–polyphenol–NLRP3 axis functions as an integrated, self-regulated network in which each component simultaneously shapes and is shaped by the others: dysbiosis primes NLRP3 and depletes protective metabolites, while inflammasome hyperactivation further destabilises microbial ecology; polyphenol biotransformation by specific taxa interrupts this feed-forward loop at multiple nodes, restoring homeostasis.

14 September 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CRClaudia María Rejano-Gordillo
Claudia María Rejano-Gordillo
FGFrancisco J. González-Rico
Francisco J. González-Rico
BMBeatriz Marín-Díaz
Beatriz Marín-Díaz
AOAna Ordiales-Talavero
Ana Ordiales-Talavero
ANAna Nacarino-Palma
Ana Nacarino-Palma
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
The liver is among the few organs having the ability to self-regenerate in response to a severe damage compromising its functionality. The Aryl hydrocarbon receptor (Ahr) is a transcription factor relevant for the detoxification of xenobiotics but also largely important for liver development and homeostasis. Hence, liver cell differentiation is developmentally modulated by Ahr through the controlled expression of pluripotency and stemness-inducing genes. Here, 2/3 partial hepatectomy (PH) was used as a clinically relevant approach to induce liver regeneration in Ahr-expressing (Ahr+/+) and Ahr-null (Ahr−/−) mice. Ahr expression and activity were early induced after 2/3 PH to be gradually downmodulated latter during regeneration. Ahr−/− mice triggered liver regeneration much faster than AhR+/+ animals, although both reached full regeneration at the latest times. At initial stages after PHx, earlier regenerating Ahr−/− livers had upregulation of cell proliferation markers and increased activation of signalling pathways related to stemness such as Hippo-YAP and Wnt/β-catenin, concomitantly with the induction of pro-inflammatory cytokines TNFa, IL6 and p65. These phenotypes, together with the improved metabolic adaptation of Ahr−/− mice after PHx and their induced sustained cell proliferation, could likely result from the expansion of undifferentiated stem cells residing in the liver expressing OCT4, SOX2, KLF4 and NANOG. We propose that Ahr needs to be induced early during regeneration to fine-tune liver regrowth to physiological values. Since Ahr deficiency did not result in liver overgrowth, its transient pharmacological inhibition could serve to improve liver regeneration in hepatectomized and transplanted patients and in those exposed to damaging liver toxins and carcinogens.